Composition and methods for enhancing oligonucleotide-directed nucleic
acid sequence alteration in vivo, ex vivo and in vitro are presented.
These methods and compositions involve cells and cell-free extracts with
altered levels or activities of a protein from the RAD52 epistasis group,
the mismatch repair group and/or the excision repair group.